ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS

被引：0
|
作者：
Landray, Martin J. [1 ]
Dalton, Neil [2 ]
Turner, Charles [3 ]
Blackwell, Lisa [1 ]
Morgan, Matthew [4 ]
Nuttall, Sarah [4 ]
Baigent, Colin [1 ]
Townend, John [4 ]
Wheeler, David C. [5 ]
机构：
[1] Univ Oxford, Oxford OX1 2JD, England
[2] Kings Coll London, London, England
[3] Guys & St Thomas London, London, England
[4] Univ Hosp Birmingham NHS, Birmingham, W Midlands, England
[5] Royal Free & Univ Coll Med Sch London, London, England
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A152 / A152
页数：1
相关论文
共 50 条
  • [1] Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases
    Fleck, C
    Schweitzer, F
    Karge, E
    Busch, M
    Stein, G
    [J]. CLINICA CHIMICA ACTA, 2003, 336 (1-2) : 1 - 12
  • [2] Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
    Tain, You-Lin
    Hsu, Chien-Ning
    [J]. TOXINS, 2017, 9 (03):
  • [3] Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
    Tsikas, Dimitrios
    Bollenbach, Alexander
    Hanff, Erik
    Kayacelebi, Arslan Arinc
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [4] Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
    Dimitrios Tsikas
    Alexander Bollenbach
    Erik Hanff
    Arslan Arinc Kayacelebi
    [J]. Cardiovascular Diabetology, 17
  • [5] Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease
    Emrich, Insa E.
    Zawada, Adam M.
    Martens-Lobenhoffer, Jens
    Fliser, Danilo
    Wagenpfeil, Stefan
    Heine, Gunnar H.
    Bode-Boeger, Stefanie M.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (03) : 201 - 213
  • [6] Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease
    Insa E. Emrich
    Adam M. Zawada
    Jens Martens-Lobenhoffer
    Danilo Fliser
    Stefan Wagenpfeil
    Gunnar H. Heine
    Stefanie M. Bode-Böger
    [J]. Clinical Research in Cardiology, 2018, 107 : 201 - 213
  • [7] Evaluation of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in patient with erectile dysfunction
    Barassi, A.
    Paroni, R.
    Fermo, I.
    Biondi, M. L.
    Pavlovic, R.
    Piediferro, G.
    Colpi, G. M.
    d'Eril, G. V. Melzi
    [J]. CLINICAL CHEMISTRY, 2007, 53 (06) : A171 - A171
  • [8] A New Player in Chronic Kidney Disease: Asymmetric Dimethylarginine (ADMA)
    Yillmaz, Mahmut Ilker
    Eyileten, Tayfun
    Yenicesu, Mujdat
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2007, 16 (03): : 93 - 101
  • [9] Decreased peripheral vascular function in patients with stage 3 and 4 chronic kidney disease who have elevated symmetric dimethylarginine but not asymmetric dimethylarginine
    Grotle, Ann-Katrin
    Kaur, Jasdeep
    Skow, Rachel
    Young, Benjamin
    Nandadeva, Damsara
    Stephens, Brandi
    Mohan, Ponnaiah
    Fadel, Paul
    [J]. PHYSIOLOGY, 2023, 38
  • [10] Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease
    Lu, Tse-Min
    Chung, Ming-Yi
    Lin, Chih-Ching
    Hsu, Chiao-Po
    Lin, Shing-Jong
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (07): : 1566 - 1572
12345